CIK 0001388320 · Non-accelerated filer<br>Smaller reporting company
Actinium Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ATNM
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 880378336
- Phone
- (646) 677-3870
- Business address
- 100 PARK AVE., 23RD FLOOR, NEW YORK, NY, 10017
- Former names
- Cactus Ventures, Inc.
- 8-K Event Agreement ended · Executive or director change
- 4 Open-market buy Director bought 100 shares at $3.95 ($395)
- 10-Q Report Quarterly Report
- 8-K Event Bylaws or fiscal year change
- UPLOAD Other SEC-generated Letter
- 10-K Report Annual Report
- D Other Notice of Sales of Unregistered Securities
- S-1 Offering Registration Statement
- 8-K Event Executive or director change
- 8-K Event Material agreement · Acquisition or sale completed · Unregistered share sale
- 8-K Event Executive or director change
- 8-K Event Executive or director change
- DEF 14C Other DEF 14C
- 8-K Event Other events
- 8-K/A Event Material agreement · Acquisition or sale completed · Unregistered share sale · Auditor change · Change in control · Executive or director change · Code of ethics change · Shell status change
- 3 Insider Initial Statement of Ownership
- SC 13D Stake Beneficial Ownership Report
- D Other Notice of Sales of Unregistered Securities
- 3 Insider Initial Statement of Ownership
- 8-K/A Event Material agreement · Acquisition or sale completed · Unregistered share sale · Auditor change · Change in control · Executive or director change · Code of ethics change · Shell status change
Page 23 of 26 · 511 filings